Clinical trialNCT03911076TerminatedPhase 2Interventional

Phase II Study of Treatment for HPV16+ ASC-US, ASC-H and LSIL

SponsorPapiVax Biotech, Inc.Enrollment16ASC-HASC-USLSIL

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

* To evaluate the safety and tolerability of the dual IM pNGVL4a Sig/E7(detox)/HSP70 DNA and single IM TA-CIN immunization regimen * To evaluate the efficacy of dual IM pNGVL4a-Sig/E7(detox)/HSP70 DNA and single IM TA-CIN immunization regimen on Human Papillomavirus (HPV) 16 clearance by Month 6

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Mark Einstein, MD, MS
Professor and Chairman, Dept. of OBS&GYN, Rutgers New Jersey Medical School, Newark, NJ 07101
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Health Awareness, Inc.
Port Saint Lucie, Florida, United States
University Hospital, Rutgers New Jersey Medical School
Newark, New Jersey, United States
Obstetrics & Gynecology Associates, Inc.
Fairfield, Ohio, United States
Austin Area Obstetrics, Gynecology, and Fertility
Austin, Texas, United States
Corpus Christi Women'S Clinic (elligo Health Research, Inc.)
Corpus Christi, Texas, United States
Macarthur Medical Center
Irving, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PVX-2

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 22 May 2019
Primary completion: 8 Jun 2022
Completion: 8 Jun 2022
Last update posted: 17 Jun 2024
Registered enrollment: 16
Registry id: NCT03911076

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.